The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person11

MYRIAD GENETICS INC

Company

14 records in the corpus

Opus Genetics, Inc.

Company

14 records in the corpus

Fulgent Genetics, Inc.

Company

12 records in the corpus

GENESCO INC

Company

2 records in the corpus

INTELLINETICS, INC.

Company

9 records in the corpus

Neuronetics, Inc.

Company

4 records in the corpus

CYTOKINETICS INC

Company

26 records in the corpus

10x Genomics, Inc.

Company

19 records in the corpus

GENERAL MILLS INC

Company

22 records in the corpus

SOPHiA GENETICS SA

Company

16 records in the corpus

MYR GROUP INC.

Company

5 records in the corpus

Primary record18

MYRIAD GENETICS INC filed 8-K

ITEM 8.01 Other Events On November 2, 2026, Myriad Genetics, Inc. (the “Company”) detected unauthorized access within its information technology network environment. Upon discovery, the Company promptly initiated its inc

05 Nov 2026 · sec daily index

MYRIAD GENETICS INC filed 8-K

ITEM 2.02 Results of Operations and Financial Condition. On November 4, 2026, Myriad Genetics, Inc. announced its financial results for the three months ended September 30, 2026. The earnings release is attached hereto a

04 Nov 2026 · sec daily index

MYRIAD GENETICS INC filed 4

SEC form 4 filed by MYRIAD GENETICS INC (CIK 899923) on 2026-11-02.

02 Nov 2026 · sec daily index

BlackRock Portfolio Management LLC filed SCHEDULE 13G/A

0002052113-26-001099.txt : 20261027 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002052113 XXXXXXXX LIVE 1 Common Stock 09/30/2026 0000899923 MYRIAD GENETICS INC 62855J104 322 NORTH 2200 WEST SALT LAKE CITY UT

27 Oct 2026 · sec daily index

MYRIAD GENETICS INC filed 8-K

ITEM 1.01 Entry into a Material Definitive Agreement. On October 19, 2026, Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Laboratory Corporation of America, a Delaware corporation (“Buyer”), entered i

20 Oct 2026 · sec daily index

MYRIAD GENETICS INC filed 8-K

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 6, 2026, Myriad Genetics, Inc. (the Company ) entered

09 Oct 2026 · sec daily index

MYRIAD GENETICS INC filed 8-K

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 6, 2026, Myriad Genetics, Inc. (the Company ) entered

09 Oct 2026 · sec daily index

MYRIAD GENETICS INC filed 4

SEC form 4 filed by MYRIAD GENETICS INC (CIK 899923) on 2026-09-22.

22 Sep 2026 · sec daily index

MYRIAD GENETICS INC filed 4

SEC form 4 filed by MYRIAD GENETICS INC (CIK 899923) on 2026-09-18.

18 Sep 2026 · sec daily index

MYRIAD GENETICS INC filed 4

SEC form 4 filed by MYRIAD GENETICS INC (CIK 899923) on 2026-09-17.

17 Sep 2026 · sec daily index

MYRIAD GENETICS INC filed 8-K

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 16, 2026, Myriad Genetics, Inc. (the Company ) anno

16 Sep 2026 · sec daily index

MYRIAD GENETICS INC filed 4

SEC form 4 filed by MYRIAD GENETICS INC (CIK 899923) on 2026-09-08.

08 Sep 2026 · sec daily index

BlackRock Portfolio Management LLC filed SCHEDULE 13G

0002052113-26-000835.txt : 20260904 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0002052113 XXXXXXXX LIVE Common Stock 08/31/2026 0000899923 MYRIAD GENETICS INC 62855J104 322 NORTH 2200 WEST SALT LAKE CITY UT 84116

04 Sep 2026 · sec daily index

SERA PROGNOSTICS, INC. filed 8-K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of New Chief Financial Officer and Treasurer effec

19 Aug 2026 · sec daily index

MYRIAD GENETICS INC filed 4

SEC form 4 filed by MYRIAD GENETICS INC (CIK 899923) on 2026-08-17.

17 Aug 2026 · sec daily index

GLENVIEW CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G/A

0000905148-26-003766.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001138995 XXXXXXXX LIVE 1 Common Stock, par value $0.01 per share 06/30/2026 0000899923 MYRIAD GENETICS INC 62855J104 322 North 2

14 Aug 2026 · sec daily index

MYRIAD GENETICS INC filed SCHEDULE 13G

, the beneficial owner of the securities reported herein. The address of the business office of each of the Reporting Persons is 632 Broadway, Suite 602, New York, NY 10012. The Investment Manager is a Delaware limited p

14 Aug 2026 · sec daily index

MYRIAD GENETICS INC filed SCHEDULE 13G

0000093751-26-000498.txt : 20260807 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0000093751 XXXXXXXX LIVE COMMON STOCK 06/30/2026 0000899923 MYRIAD GENETICS INC 62855J104 320 WAKARA WAY SALT LAKE CITY UT 84108 Rule

07 Aug 2026 · sec daily index